Biomarkers for Oncology
JH · Effective Oct 1, 2015
30 active Medicare policies list 81327, and 8 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Jul 17, 2023
JH · Effective Jul 17, 2023
JL · Effective Jul 17, 2023
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
8 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 81327 |
|---|---|---|
| Genetic Liquid Biopsy in the Management of Cancer and Cancer Surveillance The retained document does not establish a state, line of business, or indexed market. Applicability is unknown; confirm the member's plan with the payer. | Aug 22, 2026 | Covered |
| Genetic Liquid Biopsy in the Management of Cancer and Cancer Surveillance [for Indiana Medicaid] The retained document does not establish a state, line of business, or indexed market. Applicability is unknown; confirm the member's plan with the payer. | Jun 14, 2026 | Covered |
| Predictive and Prognostic Polygenic Testing The retained document does not establish a state, line of business, or indexed market. Applicability is unknown; confirm the member's plan with the payer. |
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JL · Effective Apr 24, 2025
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
J5 · Effective Jul 1, 2026
National · Effective Nov 16, 2023
National · Effective Nov 21, 2019
J5 · Effective Nov 30, 2023
National · Effective Feb 19, 2026
JL · Effective Jul 1, 2026
J9 · Effective Jul 1, 2026
J6 · Effective Jul 15, 2026
J9 · Effective Jan 1, 2024
| Jun 14, 2026 |
| Covered |
| Somatic Tumor Testing The retained document does not establish a state, line of business, or indexed market. Applicability is unknown; confirm the member's plan with the payer. | Nov 15, 2025 | Referenced |
|---|
| Policy | Effective | Status of 81327 |
|---|---|---|
| Colonoscopy, Colorectal Cancer Screening, and Related Procedures | Aug 1, 2023 | Covered |
| Policy | Effective | Status of 81327 |
|---|---|---|
| Concert Genetic Testing Oncology: Cancer Screening and Surveillance | Not recorded | Referenced |
| Policy | Effective | Status of 81327 |
|---|---|---|
| Molecular and Proteomic Diagnostic Testing for Hematology and Oncology Indications | Oct 1, 2026 | Not covered |
| Policy | Effective | Status of 81327 |
|---|---|---|
| Serologic Genetic and Molecular Screening for Colorectal Cancer | Sep 1, 2026 | Covered |